Coral Laboratories Limited (BOM:524506)

India flag India · Delayed Price · Currency is INR
500.00
-3.75 (-0.74%)
At close: Jun 18, 2026
Market Cap1.79B -33.0%
Revenue (ttm)859.00M -25.3%
Net Income163.81M -32.2%
EPS45.85 -32.2%
Shares Out 3.57M
PE Ratio10.91
Forward PEn/a
Dividend2.00 (0.40%)
Ex-Dividend Daten/a
Volume341
Open500.05
Previous Close503.75
Day's Range495.00 - 504.90
52-Week Range360.00 - 624.95
Beta0.88
AnalystsStrong Buy
Price Target480.00 (-4.0%)
Earnings DateMay 30, 2026

About Coral Laboratories

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally. The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, ora... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 197
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524506
Full Company Profile

Financial Performance

In fiscal year 2026, Coral Laboratories's revenue was 859.00 million, a decrease of -25.31% compared to the previous year's 1.15 billion. Earnings were 163.81 million, a decrease of -32.18%.

Financial Statements